Suitable reference tissues for quantitative susceptibility mapping of the brain

Magnetic Resonance in Medicine

Volumn 78, Issue 1, 2017, Pages 204-214

  Straub, Sina ^a   Schneider, Till M ^a,b   Emmerich, Julian ^a   Freitag, Martin T ^a   Ziener, Christian H ^a   Schlemmer, Heinz Peter ^a   Ladd, Mark E ^a   Laun, Frederik B ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

age dependence; brain; malignant melanoma; metastasis; quantitative susceptibility mapping; reference

Indexed keywords

BRAIN; CEREBROSPINAL FLUID; DERMATOLOGY; MAGNETIC RESONANCE; MAGNETIC SUSCEPTIBILITY; MAPPING; ONCOLOGY; PATHOLOGY; TISSUE;

AGE DEPENDENCE; MALIGNANT MELANOMA; METASTASIS; REFERENCE; SUSCEPTIBILITY MAPPING;

BRAIN MAPPING;

ADULT; AGE; AGED; ARTICLE; BASAL GANGLION; BRAIN METASTASIS; CANCER STAGING; CAPSULA INTERNA; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORPUS CALLOSUM; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MELANOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; QUANTITATIVE SUSCEPTIBILITY MAPPING; RED NUCLEUS; REFERENCE VALUE; SPLENIUM; STRAIGHT SINUS; BRAIN MAPPING; BRAIN TUMOR; DIAGNOSTIC IMAGING; FEMALE; GERMANY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS;

ADULT; AGED; BRAIN MAPPING; BRAIN NEOPLASMS; FEMALE; GERMANY; HUMANS; INTERNAL CAPSULE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84981719094     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.26369     Document Type: Article

References (41)

1. Haacke EM, Liu S, Buch S, Zheng W, Wu D, Ye Y. Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging 2015;33:1–25.
2. Wang Y, Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med 2015;73:82–101.
3. Chen WW, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, Pei MC, Pitt D, Wang Y. Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014;271:183–192.
4. Langkammer C, Liu T, Khalil M, Enzinger C, Jehna M, Fuchs S, Fazekas F, Wang Y, Ropele S. Quantitative susceptibility mapping in multiple sclerosis. Radiology 2014;267:551–559.
5. Liu T, Eskreis-Winkler S, Schweitzer AD, Chen WW, Kaplitt MG, Tsiouris AJ, Wang Y. Improved subthalamic nucleus depiction with quantitative susceptibility mapping. Radiology 2013;269:216–223.
6. Al-Radaideh AM, Wharton SJ, Lim SY, Tench CR, Morgan PS, Bowtell RW, Constantinescu CS, Gowland PA. Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome. Mult Scler 2013;19:896–903.
7. Lotfipour AK, Wharton S, Schwarz ST, Gontu V, Schafer A, Peters AM, Bowtell RW, Auer DP, Gowland PA, Bajaj NP. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging 2012;35:48–55.
8. 2-imaging at ultra-high magnetic field strength. Neuroimage 2013;65:299–314.
9. Wharton S, Bowtell R. Fiber orientation-dependent white matter contrast in gradient echo MRI. Proc Natl Acad Sci U S A 2012;109:18559–18564.
10. Lee J, Shmueli K, Fukunaga M, van Gelderen P, Merkle H, Silva AC, Duyn JH. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc Natl Acad Sci U S A 2010;107:5130–5135.
11. Wharton S, Bowtell R. Effects of white matter microstructure on phase and susceptibility maps. Magn Reson Med 2015;73:1258–1269.
12. Deistung A, Schweser F, Wiestler B, et al. Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PloS One 2013;8:1–8.
13. Chen WW, Zhu WZ, Kovanlikaya I, Kovanlikaya A, Liu T, Wang S, Salustri C, Wang Y. Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping. Radiology 2014;270:496–505.
14. Reichenbach JR, Schweser F, Serres B, Deistung A. Quantitative susceptibility mapping: concepts and applications. Clin Neuroradiol 2015;25(Suppl 2):225–230.
15. Li W, Wu B, Liu CL. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011;55:1645–1656.
16. Lim IA, Faria AV, Li X, Hsu JT, Airan RD, Mori S, van Zijl PC. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping application to determine iron content in deep gray matter structures. Neuroimage 2013;82:449–469.
17. Griswold MA, Jakob PM, Heidemann RM, Nittka M, Jellus V, Wang JM, Kiefer B, Haase A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47:1202–1210.
18. Prock T, Collins DJ, Dzik-Jurasz ASK, Leach MO. An algorithm for the optimum combination of data from arbitrary magnetic resonance phased array probes. Phys Med Biol 2002;47:N39–N46.
19. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–155.
20. Li W, Avram AV, Wu B, Xiao X, Liu CL. Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed 2014;27:219–227.
21. Wu B, Li W, Guidon A, Liu CL. Whole brain susceptibility mapping using compressed sensing. Magn Reson Med 2012;67:137–147.
22. Li W, Wang N, Yu F, Han H, Cao W, Romero R, Tantiwongkosi B, Duong TQ, Liu CL. A method for estimating and removing streaking artifacts in quantitative susceptibility mapping. Neuroimage 2015;108:111–122.
23. Hongfu S, Mahesh K, Gioia LC, Emery DJ, Butcher K, Wilman AH. Quantitative susceptibility mapping using a superposed dipole inversion method: application to intracranial hemorrhage. Magn Reson Med 2016;76:781–791.
24. Maleike D, Nolden M, Meinzer HP, Wolf I. Interactive segmentation framework of the Medical Imaging Interaction Toolkit. Comput Methods Programs Biomed 2009;96:72–83.
25. Nolden M, Zelzer S, Seitel A, et al. The Medical Imaging Interaction Toolkit: challenges and advances, Int J Comput Assist Radiol Surg 2013;8:607–620.
26. Patenaude B, Smith SM, Kennedy D, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain. Neuroimage 2011;56:907–922.
27. R Development Core Team (2008). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. http://www.R-project.org.
28. Kinoshita T, Moritani T, Hiwatashi A, et al. Clinically silent choroid plexus cyst: evaluation by diffusion-weighted MRI. Neuroradiology 2005;47:251–255.
29. Matsumae M, Kikinis R, Mórocz IA, Lorenzo AV, Sándor T, Albert MS, Black PM, Jolesz FA. Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. J Neurosurg 1996;84:982–991.
30. Barron SA, Jacobs L, Kinkel WR. Changes in size of normal lateral ventricles during aging determined by computerized tomography. Neurology 1976;26:1011–1013.
31. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863–873.
32. Ogg, RJ, Langston JW, Haacke EM, Steen RG, Taylor JS. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999;17:1141–1148.
33. Li W, Langkammer C, Chou YH, Petrovic K, Schmidt R, Song AW, Madden DJ, Ropele S, Chunlei Liu. Association between increased magnetic susceptibility of deep gray matter nuclei and decreased motor function in healthy adults. Neuroimage 2015;105:45–52.
34. Blazejewska AI, Al-Radaideh AM, Wharton S, Lim SY, Bowtell RW, Constantinescu CS, Gowland PA. Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI study. J Magn Reson Imaging 2015;41:1065–1070.
35. Khalil M, Riedlbauer B, Langkammer C, et al. Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis. Mult Scler 2014;20:1569–1577.
36. Onyszchuk G, LeVine SM, Brooks WM, Berman NE. Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci Lett 2009;452:204–208.
37. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN, Rapoport JL, Evans AC. Structural maturation of neural pathways in children and adolescents: in vivo study. Science 1999;283:1908–1911.
38. Staudt M, Krägeloh-Mann I, Grodd W. Normal myelination in childhood brains using MRI--a meta analysis. Rofo 2000;172:802–811.
39. Wong M, Schlaggar BL, Buller RS, Storch GA, Landt M. Cerebrospinal fluid protein concentration in pediatric patients defining clinically relevant reference values. Arch Pediatr Adolesc Med 2000;154:827–831.
40. Hinoda T, Fushimi Y, Okada T, Fujimoto K, Liu C, Yamamoto A, Okada T, Kido A, Togashi K. Quantitative susceptibility mapping at 3 T and 1.5 T: evaluation of consistency and reproducibility. Invest Radiol 2015;50:522–530.
41. Yao B, Li TQ, Gelderen PV, Shmueli K, de Zwart JA, Duyn JH. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 2009;44:1259–1266.